UBS Adjusts Price Target on Houlihan Lokey to $154 From $147, Keeps Neutral Rating
UBS raised its price target for Houlihan Lokey to $154 from $147, maintaining a neutral rating. The company's stock is currently trading at $123.40, down 3.54% over five days but up 0.38% year-to-date. Recent developments include a new office opening and a new managing director appointment.
How this was made
The 30-second read
Why it matters
The new target may influence short‑term trading decisions and affect comparable advisory firms.
Market read
Analyst target change provides a modest trading signal for HLI and peers.
What to watch
Potential headwinds in deal flow and macro environment could limit upside.
Background
UBS analyst coverage update for Houlihan Lokey, a U.S. investment bank.
Ticker impact
UBS raised its price target on Houlihan Lokey to $154 from $147 and kept a neutral rating.
likely modest upward pressure as investors price in the higher target.
Target raise reflects improved valuation expectations; no immediate catalyst beyond the rating change.
Market effects
May slightly lift peer investment banks and advisory firms.
Limited to U.S. financial services sector.
Low global impact.
Counterpoint
Target raise could be premature if earnings guidance does not improve.
Key entities
- companyHoulihan Lokey
U.S. investment bank providing financial advisory services.
- financial_institutionUBS
Global investment bank issuing the rating update.
